The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of pazopanib and weekly paclitaxel in metastatic or locally advanced squamous penile carcinoma patients previously treated with cisplatin-based chemotherapy: PAZOPEN study.
 
Miguel Angel Climent
Consulting or Advisory Role - GlaxoSmithKline
Expert Testimony - GlaxoSmithKline
 
Javier Puente
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag; Pfizer
 
Sergio Vazquez-Estevez
Consulting or Advisory Role - GlaxoSmithKline; Sanofi
Speakers' Bureau - GlaxoSmithKline; Sanofi
 
María José Méndez-Vidal
No Relationships to Disclose
 
Enrique Gonzalez-Billalabeitia
Consulting or Advisory Role - Astellas Pharma; Janssen-Cilag
 
Nuria Laínez
No Relationships to Disclose
 
José Pablo Maroto Rey
No Relationships to Disclose
 
Juan Francisco Rodriguez-Moreno
No Relationships to Disclose
 
Xavier Garcia del Muro
No Relationships to Disclose